Emphysema Global Market Report 2025

Description

Emphysema is a chronic lung disease that causes damage to the air sacs (alveoli) in the lungs, resulting in difficulty breathing. It is a type of chronic obstructive pulmonary disease (COPD), typically caused by smoking or prolonged exposure to air pollutants. As the alveoli weaken and lose their elasticity, air becomes trapped in the lungs, making it difficult to expel carbon dioxide and take in fresh oxygen. This leads to shortness of breath, a chronic cough, and progressively reduced lung function.

The primary types of emphysema are centrilobular and panlobular. Centrilobular refers to damage in the central part of the lung lobule, often seen in centrilobular emphysema. Treatment options for emphysema include medications, therapy, surgery, and other approaches. Diagnosis typically involves imaging tests, lung function assessments, and additional diagnostic procedures. Common complications associated with emphysema include chest infections, lung collapse, heart issues, lung holes, and other related conditions. Treatment typically occurs in hospitals, clinics, surgical centers, and other healthcare facilities.

The emphysema market research report is one of a series of new reports from The Business Research Company that provides emphysema market statistics, including the emphysema industry global market size, regional shares, competitors with the emphysema market share, detailed emphysema market segments, market trends, and opportunities, and any further data you may need to thrive in the emphysema industry. This emphysema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The emphysema market size has grown strongly in recent years. It will grow from $4.74 billion in 2024 to $4.99 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth during the historic period can be attributed to the rising prevalence of respiratory diseases, the aging population, increased smoking rates, higher levels of air pollution, growing government initiatives, and a larger population of tobacco smokers.

The emphysema market size is expected to see steady growth in the next few years. It will grow to $6.05 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth during the forecast period can be attributed to rising healthcare spending, increasing environmental pollution, higher demand for diagnostic medical devices, growing vehicular traffic, and a greater demand for minimally invasive procedures. Key trends during this period include the development of new inhalation devices, strategic partnerships, personalized medicine, telemedicine, advancements in inhalation therapies, and ongoing medical innovations.

The increasing prevalence of respiratory infections is expected to drive the growth of the emphysema market. Respiratory infections affect various parts of the respiratory system, such as the sinuses, throat, airways, and lungs. The rising number of respiratory infections can be attributed to factors such as pollution, climate change, antimicrobial resistance, urbanization, and the emergence of new pathogens. These infections can worsen emphysema by causing inflammation, damaging tissues, and increasing airway obstruction, all of which lead to further deterioration of lung function. For example, in November 2024, the Centers for Disease Control and Prevention (CDC) reported a rise in tuberculosis (TB) cases in the U.S., with 9,633 cases recorded in 2023, a 15.6% increase from the previous year. As respiratory infections continue to increase, they contribute to the growth of the emphysema market.

Companies in the emphysema market are focusing on innovations such as inhaled dual inhibitors of phosphodiesterase 3 and phosphodiesterase 4 to improve treatment for chronic obstructive pulmonary disease (COPD), including emphysema. These medications help relax the airways, reduce inflammation, and improve lung function, offering enhanced management of the disease and improving patients' quality of life. For instance, in June 2024, Verona Pharma plc, a UK-based pharmaceutical company, introduced Ohtuvayre (ensifentrine), the first inhaled dual PDE3 and PDE4 inhibitor approved by the FDA for COPD maintenance treatment. This novel inhaled therapy, combining bronchodilator and anti-inflammatory effects, marks the first new inhaled treatment in over two decades and is set to be available through specialty pharmacies.

In October 2023, Aileron Therapeutics, a U.S.-based biopharmaceutical company, acquired Lung Therapeutics for an undisclosed amount. This acquisition allows Aileron to expand its pipeline by gaining access to clinical-stage therapies, such as LTI-03, a novel peptide aimed at treating idiopathic pulmonary fibrosis. Lung Therapeutics, a company focused on developing treatments for lung diseases, has developed therapies for conditions such as emphysema, and this acquisition positions Aileron to further address life-threatening lung diseases that currently have limited treatment options.

Major players in the emphysema market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Mylan N.V., Olympus Corporation, ResMed Inc., Chiesi Farmaceutici S.p.A., University of Chicago Medicine (UChicago Medicine), Hikma Pharmaceuticals PLC, United Therapeutics Corporation, VIDA Diagnostics Inc., Kamada Limited, Pulmonx Corporation, Mereo BioPharma Group PLC, Uptake Medical Corporation, and Verona Pharma PLC.

North America was the largest region in the emphysema market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in emphysema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the emphysema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The emphysema market consists of revenues earned by entities by providing services such as diagnosis and screening services, oxygen therapy, pulmonary rehabilitation programs, and home healthcare services. The market value includes the value of related goods sold by the service provider or included within the service offering. The emphysema market also includes sales of bronchodilators, corticosteroids, oxygen therapy devices, nebulizers, and pulmonary rehabilitation products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emphysema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emphysema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The emphysema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Centrilobular; Panlobular
2) By Treatment: Medication; Therapy; Surgery; Other Treatments
3) By Diagnosis: Imaging Test; Lung Function Test; Other Diagnosis
4) By Complications: Chest Infections; Collapsed Lung; Heart Problems; Lungs Hole; Other Complications
5) By End-user: Hospitals And Clinics; Surgical Center; Other End-users
Subsegments:
1) By Centrilobular: Mild Centrilobular Emphysema; Moderate Centrilobular Emphysema; Severe Centrilobular Emphysema
2) By Panlobular: Mild Panlobular Emphysema; Moderate Panlobular Emphysema; Severe Panlobular Emphysema
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca PLC; Novartis International AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34520

1. Executive Summary

2. Emphysema Market Characteristics

3. Emphysema Market Trends And Strategies

4. Emphysema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Emphysema Growth Analysis And Strategic Analysis Framework

5.1. Global Emphysema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Emphysema Market Growth Rate Analysis
5.4. Global Emphysema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Emphysema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Emphysema Total Addressable Market (TAM)

6. Emphysema Market Segmentation

6.1. Global Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Centrilobular
Panlobular
6.2. Global Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Therapy
Surgery
Other Treatments
6.3. Global Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Test
Lung Function Test
Other Diagnosis
6.4. Global Emphysema Market, Segmentation By Complications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chest Infections
Collapsed Lung
Heart Problems
Lungs Hole
Other Complications
6.5. Global Emphysema Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Surgical Center
Other End-users
6.6. Global Emphysema Market, Sub-Segmentation Of Centrilobular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild Centrilobular Emphysema
Moderate Centrilobular Emphysema
Severe Centrilobular Emphysema
6.7. Global Emphysema Market, Sub-Segmentation Of Panlobular, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild Panlobular Emphysema
Moderate Panlobular Emphysema
Severe Panlobular Emphysema

7. Emphysema Market Regional And Country Analysis

7.1. Global Emphysema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Emphysema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emphysema Market

8.1. Asia-Pacific Emphysema Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emphysema Market

9.1. China Emphysema Market Overview
9.2. China Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emphysema Market

10.1. India Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emphysema Market

11.1. Japan Emphysema Market Overview
11.2. Japan Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emphysema Market

12.1. Australia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emphysema Market

13.1. Indonesia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emphysema Market

14.1. South Korea Emphysema Market Overview
14.2. South Korea Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emphysema Market

15.1. Western Europe Emphysema Market Overview
15.2. Western Europe Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emphysema Market

16.1. UK Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emphysema Market

17.1. Germany Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emphysema Market

18.1. France Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emphysema Market

19.1. Italy Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emphysema Market

20.1. Spain Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emphysema Market

21.1. Eastern Europe Emphysema Market Overview
21.2. Eastern Europe Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emphysema Market

22.1. Russia Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emphysema Market

23.1. North America Emphysema Market Overview
23.2. North America Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emphysema Market

24.1. USA Emphysema Market Overview
24.2. USA Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emphysema Market

25.1. Canada Emphysema Market Overview
25.2. Canada Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emphysema Market

26.1. South America Emphysema Market Overview
26.2. South America Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emphysema Market

27.1. Brazil Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emphysema Market

28.1. Middle East Emphysema Market Overview
28.2. Middle East Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emphysema Market

29.1. Africa Emphysema Market Overview
29.2. Africa Emphysema Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Emphysema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Emphysema Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emphysema Market Competitive Landscape And Company Profiles

30.1. Emphysema Market Competitive Landscape
30.2. Emphysema Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Emphysema Market Other Major And Innovative Companies

31.1. GlaxoSmithKline PLC
31.2. Takeda Pharmaceutical Company Limited
31.3. Koninklijke Philips N.V.
31.4. Teva Pharmaceutical Industries Ltd.
31.5. Boehringer Ingelheim
31.6. Mylan N.V.
31.7. Olympus Corporation
31.8. ResMed Inc.
31.9. Chiesi Farmaceutici S.p.A.
31.10. University of Chicago Medicine (UChicago Medicine)
31.11. Hikma Pharmaceuticals PLC
31.12. United Therapeutics Corporation
31.13. VIDA Diagnostics Inc.
31.14. Kamada Limited
31.15. Pulmonx Corporation

32. Global Emphysema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emphysema Market

34. Recent Developments In The Emphysema Market

35. Emphysema Market High Potential Countries, Segments and Strategies

35.1 Emphysema Market In 2029 - Countries Offering Most New Opportunities
35.2 Emphysema Market In 2029 - Segments Offering Most New Opportunities
35.3 Emphysema Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer